How safe are serotonin reuptake inhibitors for depression in patients with coronary heart disease? (Q41519173)

2 October 2017

1 reference

title

How safe are serotonin reuptake inhibitors for depression in patients with coronary heart disease? (English)

1 reference

2 October 2017

Sheline YI

1

1 reference

2 October 2017

Freedland KE

series ordinal

2

1 reference

2 October 2017

Carney RM

series ordinal

3

1 reference

2 October 2017

language of work or name

English

0 references

publication date

1 January 1997

1 reference

American Journal of Medicine

2 October 2017

1 reference

2 October 2017

102

1 reference

2 October 2017

1

1 reference

2 October 2017

54-59

1 reference

Insomnia and depression prior to myocardial infarction.

2 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

Depression following myocardial infarction. Impact on 6-month survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

Depression following myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

Major depressive disorder in coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

Major depressive disorder predicts cardiac events in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

Psychological risk factors over the life course of myocardial infarction patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

Significance of depression and cognitive impairment in patients undergoing programed stimulation of cardiac arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

The relationship between mental disorders and physical severities in patients with acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

Medical care after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

Underdiagnosis of depression in patients with coronary artery disease: the role of nonspecific symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

Antidepressants and the cardiac patient. Selecting an appropriate medication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

Cardiovascular effects of therapeutic doses of tricyclic antidepressants. A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

Psychotropic drug use and the risk of hip fracture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

The hypotensive effect of imipramine hydrocloride in patients with cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

Cardiovascular effect of imipramine and nortriptyline in elderly patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

Cardiac Antiarrhythmic Effect of Imipramine Hydrochloride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

Desmethylimipramine and imipramine on left ventricular function and the ECG: a randomized crossover design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

Comparative effects of fluoxetine and amitriptyline on cardiac function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

Possible interaction between fluoxetine and pimozide causing sinus bradycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

Mixed fluoxetine/loxapine overdose and atrial flutter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

Sinus bradycardia due to fluvoxamine overdose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

Sustained bradycardia during fluvoxamine and buspirone intoxication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

Heart block in a patient on propranolol and fluoxetine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

Drug-induced supraventricular tachycardia: a case report of fluoxetine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

Acute fluoxetine overdose: a report of 234 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

Report of a fluoxetine fatality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

Serotonin metabolism and age-related effects of antihypertensive therapy with ketanserin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

Serotonin and acute ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

The pharmacogenetics of the selective serotonin reuptake inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

Newer antidepressants and the cytochrome P450 system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

The SSRIs: advantages, disadvantages and differences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

Five fatal cases of serotonin syndrome after moclobemide-citalopram or moclobemide-clomipramine overdoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

Interaction of fluoxetine and selegiline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

Increased carbamazepine plasma concentrations after fluoxetine coadministration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

Detectable levels of fluoxetine metabolites after discontinuation: an unexpected serotonin syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A Nordic multicentre study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

Analysis of the Hamilton Depression Rating Scale factors from a double-blind, placebo-controlled trial of fluoxetine in geriatric major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

Depression and outcome in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Use of benzodiazepines in a coronary care unit.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Overdose and Safety with Fluvoxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900374-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(96)00374-9

1 reference

2 October 2017

1 reference